Andrea Tan
Stock Analyst at Goldman Sachs
(0.91)
# 3,791
Out of 4,944 analysts
45
Total ratings
37.14%
Success rate
-14.61%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrea Tan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintains: Buy | $100 → $112 | $122.05 | -8.23% | 10 | Jun 11, 2025 | |
| IOVA Iovance Biotherapeutics | Maintains: Buy | $16 → $8 | $2.47 | +224.54% | 7 | May 12, 2025 | |
| TARS Tarsus Pharmaceuticals | Maintains: Neutral | $46 → $51 | $51.80 | -1.54% | 4 | May 5, 2025 | |
| DAWN Day One Biopharmaceuticals | Maintains: Buy | $39 → $27 | $6.27 | +330.97% | 6 | Mar 25, 2025 | |
| SGMT Sagimet Biosciences | Maintains: Neutral | $23 → $6 | $9.89 | -39.33% | 5 | Jul 1, 2024 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Neutral | $31 | $18.77 | +65.16% | 1 | Jun 5, 2024 | |
| RLMD Relmada Therapeutics | Downgrades: Sell | $3 → $2 | $0.57 | +249.04% | 3 | Jun 5, 2024 | |
| KOD Kodiak Sciences | Reinstates: Sell | $2 | $8.65 | -76.88% | 1 | Dec 11, 2023 | |
| KRYS Krystal Biotech | Initiates: Buy | $160 | $146.78 | +9.01% | 1 | Nov 20, 2023 | |
| ABCL AbCellera Biologics | Maintains: Buy | $27 → $24 | $4.54 | +429.22% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $10 → $4 | $1.19 | +236.13% | 2 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $178 → $375 | $366.30 | +2.38% | 1 | Dec 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6 → $4 | $2.06 | +94.17% | 2 | May 24, 2022 |
Insmed
Jun 11, 2025
Maintains: Buy
Price Target: $100 → $112
Current: $122.05
Upside: -8.23%
Iovance Biotherapeutics
May 12, 2025
Maintains: Buy
Price Target: $16 → $8
Current: $2.47
Upside: +224.54%
Tarsus Pharmaceuticals
May 5, 2025
Maintains: Neutral
Price Target: $46 → $51
Current: $51.80
Upside: -1.54%
Day One Biopharmaceuticals
Mar 25, 2025
Maintains: Buy
Price Target: $39 → $27
Current: $6.27
Upside: +330.97%
Sagimet Biosciences
Jul 1, 2024
Maintains: Neutral
Price Target: $23 → $6
Current: $9.89
Upside: -39.33%
Arrowhead Pharmaceuticals
Jun 5, 2024
Initiates: Neutral
Price Target: $31
Current: $18.77
Upside: +65.16%
Relmada Therapeutics
Jun 5, 2024
Downgrades: Sell
Price Target: $3 → $2
Current: $0.57
Upside: +249.04%
Kodiak Sciences
Dec 11, 2023
Reinstates: Sell
Price Target: $2
Current: $8.65
Upside: -76.88%
Krystal Biotech
Nov 20, 2023
Initiates: Buy
Price Target: $160
Current: $146.78
Upside: +9.01%
AbCellera Biologics
Aug 4, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $4.54
Upside: +429.22%
Jan 9, 2023
Maintains: Sell
Price Target: $10 → $4
Current: $1.19
Upside: +236.13%
Dec 20, 2022
Maintains: Buy
Price Target: $178 → $375
Current: $366.30
Upside: +2.38%
May 24, 2022
Maintains: Neutral
Price Target: $6 → $4
Current: $2.06
Upside: +94.17%